TRIM38 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.294000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.201230E-01
Normal-vs-Stage2
3.501800E-01
Normal-vs-Stage3
2.397800E-01
Normal-vs-Stage4
2.020000E-01
Stage1-vs-Stage2
5.579200E-01
Stage1-vs-Stage3
3.649600E-01
Stage1-vs-Stage4
9.107600E-01
Stage2-vs-Stage3
8.784400E-02
Stage2-vs-Stage4
7.460200E-01
Stage3-vs-Stage4
2.203600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.263800E-01
Normal-vs-AfricanAmerican
3.624000E-01
Normal-vs-Asian
3.521600E-01
Caucasian-vs-AfricanAmerican
6.388000E-01
Caucasian-vs-Asian
6.770600E-01
AfricanAmerican-vs-Asian
8.757400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.300800E-01
Normal-vs-Female
3.307000E-01
Male-vs-Female
9.807600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.394400E-01
Normal-vs-Age(41-60Yrs)
3.667400E-01
Normal-vs-Age(61-80Yrs)
3.129400E-01
Normal-vs-Age(81-100Yrs)
3.494000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.372800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.357000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.088400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.063600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.782800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.066400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.302200E-01
Normal-vs-Daily Drinker
2.658600E-01
Normal-vs-Weekly Drinker
3.239000E-01
Normal-vs-Occasional Drinker
3.058600E-01
Normal-vs-Social Drinker
3.451800E-01
Non Drinker-vs-Daily Drinker
8.401500E-02
Non Drinker-vs-Weekly Drinker
8.836800E-01
Non Drinker-vs-Occasional Drinker
5.838200E-01
Non Drinker-vs-Social Drinker
7.589800E-01
Daily Drinker-vs-Weekly Drinker
1.426960E-01
Daily Drinker-vs-Occasional Drinker
2.787200E-01
Daily Drinker-vs-Social Drinker
3.128300E-02
Weekly Drinker-vs-Occasional Drinker
7.215200E-01
Weekly Drinker-vs-Social Drinker
6.455600E-01
Occasional Drinker-vs-Social Drinker
3.930400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.242800E-01
Normal-vs-Grade 2
2.151800E-02
Normal-vs-Grade 3
1.612350E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.821550E-02
Grade 1-vs-Grade 3
2.808400E-02
Grade 1-vs-Grade 4
4.242800E-01
Grade 2-vs-Grade 3
8.394400E-01
Grade 2-vs-Grade 4
2.151800E-02
Grade 3-vs-Grade 4
1.612350E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.556200E-01
Normal-vs-NonDiabetic
3.061200E-01
Diabetic-vs-NonDiabetic
9.215600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.226400E-01
Normal-vs-NoPancreatitis
3.207000E-01
Pancreatitis-vs-NoPancreatitis
9.643000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.145600E-01
Normal-vs-N1
3.435000E-01
N0-vs-N1
2.556400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.629000E-01
Normal-vs-TP53-NonMutant
2.777800E-01
TP53-Mutant-vs-TP53-NonMutant
6.476600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
